{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:36:29Z","timestamp":1790724989789,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preclinical studies demonstrated that glucagon-like peptide 1 (GLP-1) is locally synthesized in taste bud cells and that GLP-1 receptor exists on the gustatory nerves in close proximity to GLP-1-containing taste bud cells. This local paracrine GLP-1 signalling seems to be specifically involved in the perception of sweets. However, the role of GLP-1 in taste perception remains largely unaddressed in clinical studies. Whether any weight-reducing effects of GLP-1 receptor agonists are mediated through the modulation of taste perception is currently unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is an investigator-initiated, randomized single-blind, placebo-controlled clinical trial. We will enrol 30 women with obesity and polycystic ovary syndrome (PCOS). Participants will be randomized in a 1:1 ratio to either semaglutide 1.0\u2009mg or placebo for 16\u2009weeks. The primary endpoints are alteration of transcriptomic profile of tongue tissue as changes in expression level from baseline to follow-up after 16\u2009weeks of treatment, measured by RNA sequencing, and change in taste sensitivity as detected by chemical gustometry. Secondary endpoints include change in neural response to visual food cues and to sweet-tasting substances as assessed by functional MRI, change in body weight, change in fat mass and change in eating behaviour and food intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This is the first study to investigate the role of semaglutide on taste perception, along with a neural response to visual food cues in reward processing regions. The study may identify the tongue and the taste perception as a novel target for GLP-1 receptor agonists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and disseminations<\/jats:title>\n                    <jats:p>The study has been approved by the Slovene National Medical Ethics Committee and will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Results will be submitted for publication in an international peer-reviewed scientific journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04263415\">NCT04263415<\/jats:ext-link>\n                      . Retrospectively registered on 10 February 2020\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-021-05442-y","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T04:03:35Z","timestamp":1626667415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-8803","authenticated-orcid":false,"given":"Mojca","family":"Jensterle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ferjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jernej","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"\u0160uput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Vovk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-5254","authenticated-orcid":false,"given":"Andrej","family":"Jane\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"issue":"1","key":"5442_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.appet.2006.02.007","volume":"47","author":"C de Graaf","year":"2006","unstructured":"de Graaf C. Effects of snacks on energy intake: an evolutionary perspective. Appetite. 2006;47(1):18\u201323. https:\/\/doi.org\/10.1016\/j.appet.2006.02.007.","journal-title":"Appetite."},{"issue":"4","key":"5442_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrendo.2015.7","volume":"11","author":"SS-C Calvo","year":"2015","unstructured":"Calvo SS-C, Egan JM. The endocrinology of taste receptors. Nat Rev Endocrinol. 2015;11(4):213\u201327. https:\/\/doi.org\/10.1038\/nrendo.2015.7.","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"5442_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1534582305280031","volume":"4","author":"AC Spector","year":"2005","unstructured":"Spector AC, Travers SP. The representation of taste quality in the mammalian nervous system. Behav Cogn Neurosci Rev. 2005;4(3):143\u201391. https:\/\/doi.org\/10.1177\/1534582305280031.","journal-title":"Behav Cogn Neurosci Rev"},{"issue":"7","key":"5442_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tins.2010.04.002","volume":"33","author":"A Carleton","year":"2010","unstructured":"Carleton A, Accolla R, Simon SA. Coding in the mammalian gustatory system. Trends Neurosci. 2010;33(7):326\u201334. https:\/\/doi.org\/10.1016\/j.tins.2010.04.002.","journal-title":"Trends Neurosci."},{"issue":"4","key":"5442_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tem.2009.01.006","volume":"20","author":"B Martin","year":"2009","unstructured":"Martin B, Maudsley S, White CM, Egan JM. Hormones in the naso-oropharynx: endocrine modulation of taste and smell. Trends Endocrinol Metab TEM. 2009;20(4):163\u201370. https:\/\/doi.org\/10.1016\/j.tem.2009.01.006.","journal-title":"Trends Endocrinol Metab TEM."},{"issue":"4","key":"5442_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.physbeh.2012.04.004","volume":"107","author":"H-R Berthoud","year":"2012","unstructured":"Berthoud H-R, Zheng H. Modulation of taste responsiveness and food preference by obesity and weight loss. Physiol Behav. 2012;107(4):527\u201332. https:\/\/doi.org\/10.1016\/j.physbeh.2012.04.004.","journal-title":"Physiol Behav."},{"issue":"1","key":"5442_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.appet.2011.05.107","volume":"57","author":"F Sartor","year":"2011","unstructured":"Sartor F, Donaldson LF, Markland DA, Loveday H, Jackson MJ, Kubis H-P. Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation. Appetite. 2011;57(1):237\u201346. https:\/\/doi.org\/10.1016\/j.appet.2011.05.107.","journal-title":"Appetite."},{"issue":"10","key":"5442_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S0899-9007(00)00403-2","volume":"16","author":"SS Schiffman","year":"2000","unstructured":"Schiffman SS, Graham BG, Sattely-Miller EA, Peterson-Dancy M. Elevated and sustained desire for sweet taste in African-Americans: a potential factor in the development of obesity. Nutr Burbank Los Angel Cty Calif. 2000;16(10):886\u201393. https:\/\/doi.org\/10.1016\/S0899-9007(00)00403-2.","journal-title":"Nutr Burbank Los Angel Cty Calif."},{"issue":"1","key":"5442_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1471-4159.2008.05397.x","volume":"106","author":"Y-K Shin","year":"2008","unstructured":"Shin Y-K, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, et al. Modulation of taste sensitivity by GLP-1 signaling. J Neurochem. 2008;106(1):455\u201363. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05397.x.","journal-title":"J Neurochem."},{"issue":"1","key":"5442_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1749-6632.2009.03920.x","volume":"1170","author":"B Martin","year":"2009","unstructured":"Martin B, Dotson CD, Shin Y-K, Ji S, Drucker DJ, Maudsley S, et al. Modulation of taste sensitivity by GLP-1 signaling in taste buds. Ann N Y Acad Sci. 2009;1170(1):98\u2013101. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.03920.x.","journal-title":"Ann N Y Acad Sci."},{"issue":"11","key":"5442_CR11","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1194\/jlr.M025874","volume":"53","author":"C Martin","year":"2012","unstructured":"Martin C, Passilly-Degrace P, Chevrot M, Ancel D, Sparks SM, Drucker DJ, et al. Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res. 2012;53(11):2256\u201365. https:\/\/doi.org\/10.1194\/jlr.M025874.","journal-title":"J Lipid Res."},{"issue":"6","key":"5442_CR12","first-page":"2268","volume":"29","author":"S Takai","year":"2015","unstructured":"Takai S, Yasumatsu K, Inoue M, Iwata S, Yoshida R, Shigemura N, et al. Glucagon-like peptide-1 is specifically involved in sweet taste transmission. FASEB J Off Publ Fed Am Soc Exp Biol. 2015;29(6):2268\u201380.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol."},{"issue":"1","key":"5442_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2337\/dc08-1355","volume":"32","author":"M Nauck","year":"2009","unstructured":"Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (Liraglutide Effect and Action in Diabetes)-2 study. Diabetes Care. 2009;32(1):84\u201390. https:\/\/doi.org\/10.2337\/dc08-1355.","journal-title":"Diabetes Care."},{"issue":"3","key":"5442_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1464-5491.2009.02666.x","volume":"26","author":"M Marre","year":"2009","unstructured":"Marre M, Shaw J, Br\u00e4ndle M, Bebakar WMW, Kamaruddin NA, Strand J, et al. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU). Diabet Med J Br Diabet Assoc. 2009;26(3):268\u201378. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02666.x.","journal-title":"Diabet Med J Br Diabet Assoc."},{"issue":"6","key":"5442_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2337\/dc14-1630","volume":"38","author":"LV Gaal","year":"2015","unstructured":"Gaal LV, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care. 2015;38(6):1161\u201372. https:\/\/doi.org\/10.2337\/dc14-1630.","journal-title":"Diabetes Care."},{"issue":"1","key":"5442_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1411892.","journal-title":"N Engl J Med."},{"issue":"6","key":"5442_CR17","first-page":"784","volume":"38","author":"J van Can","year":"2014","unstructured":"van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WHM. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes 2005. 2014;38(6):784\u201393.","journal-title":"Int J Obes 2005"},{"issue":"18","key":"5442_CR18","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","volume":"58","author":"J Lau","year":"2015","unstructured":"Lau J, Bloch P, Sch\u00e4ffer L, Pettersson I, Spetzler J, Kofoed J, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370\u201380. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00726.","journal-title":"J Med Chem."},{"issue":"9","key":"5442_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351. https:\/\/doi.org\/10.1111\/dom.12932.","journal-title":"Diabetes Obes Metab."},{"key":"5442_CR20","doi-asserted-by":"crossref","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346 [cited 2020 Oct 28]. Available from: https:\/\/www.bmj.com\/content\/346\/bmj.e7586.","DOI":"10.1136\/bmj.e7586"},{"issue":"9","key":"5442_CR21","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318. https:\/\/doi.org\/10.1093\/humrep\/dey256.","journal-title":"Hum Reprod."},{"issue":"12","key":"5442_CR22","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1089\/cmb.2012.0283","volume":"20","author":"SN Hart","year":"2013","unstructured":"Hart SN, Therneau TM, Zhang Y, Poland GA, Kocher J-P. Calculating sample size estimates for RNA sequencing data. J Comput Biol J Comput Mol Cell Biol. 2013;20(12):970\u20138. https:\/\/doi.org\/10.1089\/cmb.2012.0283.","journal-title":"J Comput Biol J Comput Mol Cell Biol."},{"issue":"9","key":"5442_CR23","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/jn\/134.9.2372","volume":"134","author":"B de Lauzon","year":"2004","unstructured":"de Lauzon B, Romon M, Deschamps V, Lafay L, Borys J-M, Karlsson J, et al. The Three-Factor Eating Questionnaire-R18 is able to distinguish among different eating patterns in a general population. J Nutr. 2004;134(9):2372\u201380. https:\/\/doi.org\/10.1093\/jn\/134.9.2372.","journal-title":"J Nutr."},{"issue":"1","key":"5442_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","volume":"29","author":"AJ Stunkard","year":"1985","unstructured":"Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71\u201383. https:\/\/doi.org\/10.1016\/0022-3999(85)90010-8.","journal-title":"J Psychosom Res."},{"key":"5442_CR25","doi-asserted-by":"publisher","unstructured":"Jensterle M, DeVries JH, Battelino T, Battelino S, Yildiz B, Janez A. Glucagon-like peptide-1, a matter of taste? Rev Endocr Metab Disord. 2020. https:\/\/doi.org\/10.1007\/s11154-020-09609-x.","DOI":"10.1007\/s11154-020-09609-x"},{"key":"#cr-split#-5442_CR26.1","doi-asserted-by":"crossref","unstructured":"Archer NS, Liu D, Shaw J, Hannan G, Duesing K, Keast R. A Comparison of collection techniques for gene expression analysis of human oral taste tissue. PLoS One. 2016;11","DOI":"10.1371\/journal.pone.0152157"},{"key":"#cr-split#-5442_CR26.2","unstructured":"(3) [cited 2020 Oct 19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4807031\/."},{"issue":"1","key":"5442_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma Oxf Engl. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinforma Oxf Engl."},{"issue":"4","key":"5442_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417\u20139. https:\/\/doi.org\/10.1038\/nmeth.4197.","journal-title":"Nat Methods."},{"issue":"10","key":"5442_CR29","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288\u201397. https:\/\/doi.org\/10.1093\/nar\/gks042.","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"5442_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol."},{"issue":"3","key":"5442_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93(3):491\u2013507. https:\/\/doi.org\/10.1093\/biomet\/93.3.491.","journal-title":"Biometrika."},{"issue":"8","key":"5442_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi H, Muruganujan A, Casagrande JT, Thomas PD. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013;8(8):1551\u201366. https:\/\/doi.org\/10.1038\/nprot.2013.092.","journal-title":"Nat Protoc."},{"issue":"7","key":"5442_CR33","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41366-018-0303-y","volume":"43","author":"N Archer","year":"2019","unstructured":"Archer N, Shaw J, Cochet-Broch M, Bunch R, Poelman A, Barendse W, et al. Obesity is associated with altered gene expression in human tastebuds. Int J Obes. 2019;43(7):1475\u201384. https:\/\/doi.org\/10.1038\/s41366-018-0303-y.","journal-title":"Int J Obes."},{"issue":"2","key":"5442_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/aps.2011.168","volume":"33","author":"G Hansen","year":"2012","unstructured":"Hansen G, Jelsing J, Vrang N. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats. Acta Pharmacol Sin. 2012;33(2):194\u2013200. https:\/\/doi.org\/10.1038\/aps.2011.168.","journal-title":"Acta Pharmacol Sin."},{"key":"5442_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.physbeh.2017.03.045","volume":"177","author":"KM Hyde","year":"2017","unstructured":"Hyde KM, Blonde GD, le Roux CW, Spector AC. Liraglutide suppression of caloric intake competes with the intake-promoting effects of a palatable cafeteria diet, but does not impact food or macronutrient selection. Physiol Behav. 2017;177:4\u201312. https:\/\/doi.org\/10.1016\/j.physbeh.2017.03.045.","journal-title":"Physiol Behav."},{"issue":"1","key":"5442_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2337\/db06-0565","volume":"56","author":"K Raun","year":"2007","unstructured":"Raun K, von Voss P, Gotfredsen CF, Golozoubova V, Rolin B, Knudsen LB. Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes. 2007;56(1):8\u201315. https:\/\/doi.org\/10.2337\/db06-0565.","journal-title":"Diabetes."},{"key":"5442_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.peptides.2013.07.015","volume":"47","author":"X Zhang","year":"2013","unstructured":"Zhang X, Wang Y, Long Y, Wang L, Li Y, Gao F, et al. Alteration of sweet taste in high-fat diet induced obese rats after 4 weeks treatment with exenatide. Peptides. 2013;47:115\u201323. https:\/\/doi.org\/10.1016\/j.peptides.2013.07.015.","journal-title":"Peptides."},{"key":"5442_CR38","doi-asserted-by":"publisher","unstructured":"Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D, et al. GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity. J Clin Endocrinol Metab. 2020;105(5):1552\u201363.\u00a0 https:\/\/doi.org\/10.1210\/clinem\/dgz140.","DOI":"10.1210\/clinem\/dgz140"},{"issue":"4","key":"5442_CR39","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.dsx.2019.06.021","volume":"13","author":"M-C Brindisi","year":"2019","unstructured":"Brindisi M-C, Brondel L, Meillon S, Barthet S, Grall S, Fenech C, et al. Proof of concept: effect of GLP-1 agonist on food hedonic responses and taste sensitivity in poor controlled type 2 diabetic patients. Diabetes Metab Syndr. 2019;13(4):2489\u201394. https:\/\/doi.org\/10.1016\/j.dsx.2019.06.021.","journal-title":"Diabetes Metab Syndr."},{"key":"5442_CR40","doi-asserted-by":"crossref","unstructured":"Dub\u00e9 M-C, D\u2019Amours M, Weisnagel SJ. Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes. Diab Obes Metab. 2020;22(8):1417\u201324.","DOI":"10.1111\/dom.14050"},{"issue":"11","key":"5442_CR41","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2337\/dc16-2113","volume":"40","author":"JS ten Kulve","year":"2017","unstructured":"ten Kulve JS, Veltman DJ, Gerdes VEA, van Bloemendaal L, Barkhof F, Deacon CF, et al. Elevated postoperative endogenous GLP-1 levels mediate effects of Roux-en-Y gastric bypass on neural responsivity to food cues. Diabetes Care. 2017;40(11):1522\u20139. https:\/\/doi.org\/10.2337\/dc16-2113.","journal-title":"Diabetes Care."},{"issue":"12","key":"5442_CR42","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.2337\/db14-0849","volume":"63","author":"L van Bloemendaal","year":"2014","unstructured":"van Bloemendaal L, IJzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, et al. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014;63(12):4186\u201396. https:\/\/doi.org\/10.2337\/db14-0849.","journal-title":"Diabetes."},{"issue":"2","key":"5442_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2337\/dc15-0772","volume":"39","author":"JS Ten Kulve","year":"2016","unstructured":"Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Drent ML, Diamant M, et al. Liraglutide reduces CNS activation in response to visual food cues only after short-term treatment in patients with type 2 diabetes. Diabetes Care. 2016;39(2):214\u201321. https:\/\/doi.org\/10.2337\/dc15-0772.","journal-title":"Diabetes Care."},{"issue":"1","key":"5442_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JOE-15-0461","volume":"229","author":"JS Ten Kulve","year":"2016","unstructured":"Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PFC, Ruh\u00e9 HG, Barkhof F, et al. Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption. J Endocrinol. 2016;229(1):1\u201312. https:\/\/doi.org\/10.1530\/JOE-15-0461.","journal-title":"J Endocrinol."},{"issue":"10","key":"5442_CR45","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/oby.21200","volume":"23","author":"L van Bloemendaal","year":"2015","unstructured":"van Bloemendaal L, Veltman DJ, ten Kulve JS, Drent ML, Barkhof F, Diamant M, et al. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity. 2015;23(10):2075\u201382. https:\/\/doi.org\/10.1002\/oby.21200.","journal-title":"Obesity."},{"key":"5442_CR46","doi-asserted-by":"publisher","unstructured":"Perea-Martinez I, Nagai T, Chaudhari N. Functional cell types in taste buds have distinct longevities. PLoS One. 2013;\u00a08(1):e53399. https:\/\/doi.org\/10.1371\/journal.pone.0053399.","DOI":"10.1371\/journal.pone.0053399"},{"issue":"4","key":"5442_CR47","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.neuroscience.2006.05.061","volume":"141","author":"R Hamamichi","year":"2006","unstructured":"Hamamichi R, Asano-Miyoshi M, Emori Y. Taste bud contains both short-lived and long-lived cell populations. Neuroscience. 2006;141(4):2129\u201338. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.061.","journal-title":"Neuroscience."},{"issue":"2","key":"5442_CR48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/ijms22020902","volume":"22","author":"M Jensterle","year":"2021","unstructured":"Jensterle M, Rizzo M, Janez A. Glucagon-like peptide 1 and taste perception: from molecular mechanisms to potential clinical implications. Int J Mol Sci. 2021;22(2):902. https:\/\/doi.org\/10.3390\/ijms22020902.","journal-title":"Int J Mol Sci."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05442-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05442-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T04:26:19Z","timestamp":1626668779000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05442-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5442"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05442-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<i>Ethics approval<\/i>The study has been approved by the Slovene National Medical Ethics Committee. It is registered at the\n                      \n                      NCT04263415.It will be carried out under the surveillance and guidelines of the Good Clinical Practice and in accordance with the Helsinki Declaration.<i>Consent<\/i>Written consent was obtained by the principal investigators A.J. and M.J. Sufficient time will be given before written informed consent is obtained by the investigators. They will be fully informed of their rights as well as responsibilities while participating in the trial. An English translation of the informed consent form is provided in supplementary file\n                      \n                      .<i>Confidentiality<\/i>Personal information about potential and enrolled participants will be collected, shared and maintained in accordance with GDPR in order to protect confidentiality before, during and after the trial.<i>Harms<\/i>All AEs will be collected from the first drug administration and in all following contacts with participants throughout the trial. All AEs will be noted in the CRF and recorded in the end-of-trial form to the Slovenian Medicines Agency and in the report to the ethics committee (if requested) no later than 90\u2009days after trial completion. In case of a SAE, the report will be immediately (and no later than 2\u2009days after becoming aware) sent to the Slovenian Medicines Agency and the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.J., T.B., S.B., D.S. A.V. and J.K. declare that they have no competing interests in this work. S.F. received lecture fees from NovoNordisk. A.J. is a member of the Advisory Boards of Novo Nordisk on insulin. None of the authors has any significant competing financial, professional or personal interests that might have influenced the performance or presentation of the work described in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"464"}}